MAR 18, 2016 1:19 PM PDT

New Component of Macrophage Metabolism Discovered

WRITTEN BY: Kara Marker
How are macrophage immune cells activated during an inflammatory response when pathogens invade? Scientists thought they knew this and more, but recent studies from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg discovered something different.
 
Upon activation, macrophage metabolism pathways lead to the production of antimicrobial substances and fatty acids which deliver important resources during an infection. With their new discoveries into how these pathways work, the researchers, who study was recently published in the Journal of Biological Chemistry may have also developed a new approach for treating chronic inflammatory diseases.
 
Macrophages are key immune cells of the innate immune system, the system of first-responder cells that react when pathogens invade. Macrophages are activated upon recognition of pathogen antigens or contact with cytokines, and their activation reprograms macrophage metabolism.
 
"A hungry macrophage"

Hif1 is important protein for this very metabolism reprogramming, but it is also known to exist in cases of cancer. Cancer cells exist in an oxygen-poor tumor environment, which stabilizes Hif1 and prevents the tumor from being degraded. This causes less pyruvate to be introduced into the citric acid cycle, which is vital for producing energy for the body to perform multiple functions.
 
Apparently, Hif1 is also found in its stabilized forms in activate macrophages even though it is not an oxygen-poor environment. Previously, scientists thought this meant the metabolic pathways stemming from macrophage activation were similar to cancer cell pathways. However, the recent study from the University of Luxembourg instead showed that macrophages are able to facilitate pyruvate into the citric acid cycle despite Hif1 stabilization, allowing energy production to continue like normal.
 
"Conversion of pyruvate is a pivotal step in the inflammatory event, and thus presents a starting point for developing anti-inflammatory therapies," said Karsten Hiller, PhD. "This would be helpful for diseases associated with an excessive inflammatory response, such as allergies or septic shock."
 
Because of their ability, macrophages can also produce an “endogenous antibiotic” called itaconic acid and fatty acids needed for macrophage growth.
 
 
Source: University of Luxembourg
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
OCT 02, 2020
Immunology
Stop the Clot: A New Antibody Treatment for Thrombosis
OCT 02, 2020
Stop the Clot: A New Antibody Treatment for Thrombosis
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from ...
OCT 12, 2020
Genetics & Genomics
The Malaria Parasite Can Change Host Cell Genetics
OCT 12, 2020
The Malaria Parasite Can Change Host Cell Genetics
Mosquitoes can transmit the malaria-causing Plasmodium parasite to humans. Malaria was estimated to have caused the deat ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 25, 2020
Immunology
Another COVID-19 vaccine shows promising results!
NOV 25, 2020
Another COVID-19 vaccine shows promising results!
A week ago, another biotechnology company "Moderna" announced the preliminary results from its COVID-19 vaccin ...
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
Loading Comments...